Target intelligence / Profile preview

Cellular apoptosis pathway (None)

Target
None
Molecular classification
Biological pathway/process, Proteases (caspases), Receptors (death receptors like Fas, TNF receptors), Adaptor proteins (FADD, TRADD, Apaf-1), Regulatory proteins (Bcl-2 family members), Mitochondrial proteins
01

Overview

The cellular apoptosis pathway represents a highly regulated form of programmed cell death characterized by distinct morphological and biochemical changes including cell shrinkage, chromatin condensation, DNA fragmentation, and formation of apoptotic bodies[3]. The pathway operates through two main routes: the intrinsic (mitochondrial) pathway, initiated by intracellular stress signals such as DNA damage or growth factor deprivation[1][4], and the extrinsic pathway, triggered by external signals through death receptors like Fas and TNF receptors[3]. Both pathways converge on the activation of executioner caspases (particularly caspase-3, -6, and -7), which systematically degrade cellular components[5]. The intrinsic pathway involves the Bcl-2 family proteins that regulate mitochondrial outer membrane permeabilization, leading to cytochrome c release and apoptosome formation with Apaf-1 and procaspase-9[1]. The extrinsic pathway forms the death-inducing signaling complex (DISC) containing FADD and caspase-8[3]. A critical feature distinguishing apoptosis from necrosis is the externalization of phosphatidylserine on the cell surface, enabling recognition and phagocytic removal of apoptotic cells without inflammatory response[2][5]. In healthy adults, approximately 50 to 70 billion cells undergo apoptosis daily, playing essential roles in development, tissue homeostasis, and immunity[3]. Dysregulation of this pathway contributes to various diseases, with excessive apoptosis causing atrophy and insufficient apoptosis enabling cancer development[3].

Other names
Programmed cell death pathwayApoptotic pathwayApoptosis signaling pathway
02

Mechanism of action

Bcl-2 family modulation (promoting or inhibiting mitochondrial outer membrane permeabilization), Death receptor activation (extrinsic pathway initiation), Caspase activation or inhibition, IAP protein inhibition, p53 pathway activation

03

Biological functions

Programmed cell deathCell cycle regulationTissue homeostasisEmbryonic development (e.g., digit separation)Elimination of damaged or unwanted cellsImmune response regulationCellular stress response
04

Disease associations

Cancer (insufficient apoptosis leads to uncontrolled cell proliferation)Neurodegenerative diseases (excessive apoptosis)Autoimmune disordersDevelopmental abnormalitiesAtrophy (excessive apoptosis)Viral infections (can trigger apoptotic pathways)
05

Safety considerations

Excessive apoptosis induction can cause tissue damage and organ toxicityInsufficient apoptosis inhibition may promote cancer developmentOff-target effects on normal rapidly dividing cellsPotential for inflammatory responses if phagocytic clearance is impaired
06

Interacting drugs

Bcl-2 inhibitors (venetoclax and related compounds)

4 more in the full profile.

07

Biomarkers

Caspase-3 activationPhosphatidylserine externalizationCytochrome c releaseDNA fragmentation (laddering pattern)Bcl-2 family protein expression levelsPARP cleavage

Beyond the preview

Go deeper on Cellular apoptosis pathway (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular apoptosis pathway (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call